Navigation Links
New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medical's NICOM® Bioreactance® Technology to Guide Goal Directed Intraoperative Therapy
Date:10/17/2011

TEL-AVIV, Israel and VANCOUVER, Washington, October 17, 2011 /PRNewswire/ --

Results from a study validating Cheetah Medical's non-invasive NICOM system for use in surgery to guide fluid management were presented October 16 at the 2011 American Society of Anesthesiologists Annual Meeting in Chicago. This new study complements a strong body of evidence that demonstrates that when anesthesiologists base delivery of intravenous fluids on repetitive measurements of cardiac output, they are able to significantly reduce a host of complications associated with surgery and the length of hospital stay. This guided approach to deliver fluids is known as Goal Directed Therapy (GDT).

The Cheetah NICOM has been validated to provide highly accurate continuous hemodynamic information that can be reliably used to guide fluid management and support GDT. In this study, Duke Anesthesia researchers used Cheetah Medical's non-invasive NICOM® cardiac output & hemodynamic monitoring system alongside the invasive legacy transesophageal Doppler. Study investigators compared readings obtained with the legacy system to the NICOM in 61 patients as they underwent major surgery and found a consistent and significant correlation between both devices' readings and directions on fluid management. In addition, results indicated that the invasive Doppler device was twice as likely to fail to provide readings during the case for technical reasons as compared to the non-invasive NICOM.

"The results from this study add to a large body of evidence showing that perioperative Goal Directed Therapy using non-invasive hemodynamic monitors should be considered in patients undergoing major surgery or in high risk patients. This strategy improves patient outcomes and reduces length of hospital stay," said Tong J. Gan, MD Professor of Anesthesiology and Vice Chair for Clinical Research at Duke University Medical Center and the study's Principal Investigator.
'/>"/>

SOURCE Cheetah Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Menieres Disease at International Conference
2. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
3. Researchers From More Than 30 Countries Share Findings About the Use of Ultrasound in the Prevention, Diagnosis and Treatment of Heart Disease
4. New findings by UCR scientists hold big promise for fight against mosquito-borne diseases
5. Ceregene Reports New Findings Regarding How Parkinsons Brains Respond to Neurotrophic Factors
6. Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
7. New findings promising for transformation optics, cloaking
8. Findings show promise for nuclear fusion test reactors
9. No New Findings in Atrazine Study Promoted by Discredited Researcher, According to the Hudson Institute Center for Global Food Issues
10. Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings
11. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ... developing novel mid- to late-stage cardiovascular drug candidates, ... in its first round of financing. The Series ... and Hercules Bioventures with participation from investors that ... pharmaceutical executive, Dr. Larry Hsu , the ...
(Date:8/28/2014)... Earlier this month, a report ... with the U.S. Air Force on the performance of ... that this type of fuel made from mustard seeds, ... important to America’s Eco friendly future. In fact, every ... to become independent of foreign oil over the next ...
(Date:8/27/2014)... Varian Medical Systems today broke ground ... Lake City manufacturing facility and allow for the consolidation ... create 1,000 new full time jobs in the state ... home to hardworking people with immense engineering and technical ... success in the manufacturing of our state-of-the-art X-ray technology,” ...
(Date:8/27/2014)... YORK , Aug. 27, 2014 /PRNewswire/ ... research report is available in its catalogue: ... 2014-2018 http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... materials are materials that are readily decomposed ... differs from conventional non-degradable packaging in terms ...
Breaking Biology Technology:Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 2Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 3Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 4Can Small Farmers and a New Seed Based Biofuel “Green” the World? Major Universities and Even the U.S. Air Force Seem to Think So 5Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7
... p.m. EDT -, VALENCIA, Calif., Aug. 11 ... for the second,quarter ended June 30, 2008., For ... $80.9,million, compared to $75.4 million for the second quarter ... and development,(R&D) expenses which totaled $67.6 million for this ...
... Aug. 11 Immtech Pharmaceuticals,Inc. (Amex: IMM ) ... 2008., For the three months ended June 30, ... three months ended June 30, 2007. The increase,was primarily ... from operations for the three months ended June 30, ...
... Informed Medical Communications,(IMC), a leading provider of ... position today on recent revisions,to the PhRMA Code. ... Code," noted Dr. Jaime Nguyen, Medical Director/Compliance Officer,for ... continually monitored,the compliance trends so that our services ...
Cached Biology Technology:MannKind Corporation Reports Second Quarter Financial Results 2MannKind Corporation Reports Second Quarter Financial Results 3MannKind Corporation Reports Second Quarter Financial Results 4MannKind Corporation Reports Second Quarter Financial Results 5MannKind Corporation Reports Second Quarter Financial Results 6Immtech Reports Fiscal First Quarter 2009 Results 2Immtech Reports Fiscal First Quarter 2009 Results 3Informed Medical Communications Highlights Opportunity in Revised PhRMA Code 2
(Date:8/28/2014)... Researchers at the University of Minnesota have developed an ... be used for muscle regeneration research as well as ... , The research is published in the current edition ... is no treatment for FSHD, which is thought by ... dystrophy. FSHD is an unusual genetic disorder because, unlike ...
(Date:8/28/2014)... unique method for delivering compounds that could ... and AIDS may be possible, thanks to ... Sciences., A semi-soft vaginal suppository made from ... with the antiviral drug Tenofovir provides a ... the spread of sexually transmitted infections during ...
(Date:8/28/2014)... More than 25 million kilometres of new roads will ... will slice into Earth,s last wildernesses, where they bring ... , Now, an ambitious study has created a ... to try to balance the competing demands of development ... an ,environmental-values, layer that estimates that natural importance of ...
Breaking Biology News(10 mins):UMN researchers find animal model for understudied type of muscular dystrophy 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3
... This press release is available in Spanish ... losses to the atmosphere through volatilization also rise. ... (USDA) scientists found that herbicide volatilization consistently resulted in ... Agricultural Research Service (ARS) soil scientist Timothy ...
... it has not stopped her from working. Thanks in part ... her 13th year as an account executive for a firm ... are not as fortunate. In the United States, the ... as systemic sclerosis, is two to three times that of ...
... of scientists has produced a new map of the ... an ultra-nutritious potato that could help feed the world,s ... genome of the potato, the consortium has, for the ... Resulting insights into the growth and development of potatoes ...
Cached Biology News:Researchers study pesticide pathways into the atmosphere 2Scleroderma study identifies roadblocks to employment 2Scleroderma study identifies roadblocks to employment 3
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Request Info...
Request Info...
... Nebulizers are available in two product models - ... two models is that the 6000AT+ includes a ... drier aerosol for improved detection limits and reduced ... a range of elements by 10-40 times. Note ...
Biology Products: